Evidence map›Paper›PMID 37770909›Full record

ArticleJournal of translational medicine2023

Tyrosine phosphorylation of band 3 impairs the storage quality of suspended red blood cells in the Tibetan high-altitude polycythemia population.

Xiaodong Wu, Zhijuan Liu, Doudou Hao, Qin Zhao, Wanjing Li, Maodi Xie, Xia Feng, Xia Liao, Siyuan Chen, Siyu Wang and 13 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 1 country.

Xiaodong WuDepartment of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Zhijuan LiuDepartment of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Doudou HaoDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Qin ZhaoDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Wanjing LiCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Maodi XieLaboratory of Mitochondria and Metabolism, Department of Anesthesiology, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu, 610041, China.
Xia FengDepartment of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Xia LiaoDepartment of Critical Care Medicine, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Siyuan ChenDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Siyu WangDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Chaohua ZhouDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Wenchun LongDepartment of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Yajun ZhongDepartment of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China.
Shen LiCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Ye CaoCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Hong WangCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China.
Aiping WangDepartment of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Yuehong XuDepartment of Blood Transfusion, People's Hospital of Tibet Autonomous Region, Lhasa, 851400, Tibet, People's Republic of China.
Min HuangDepartment of Blood Transfusion, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, 610041, People's Republic of China.
Jiaxin LiuCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. jxliu@ibt.pumc.edu.cn.
Rui ZhongCenter of Biomedical Engineering, Institute of Blood Transfusion, Chinese Academy of Medical Sciences and Peking Union Medical College, Huacai Rd #26, Chenghua District, Chengdu, 610052, People's Republic of China. zhongrui@ibt.pumc.edu.cn.
Yunhong WuDepartment of Endocrinology and Metabolism, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. wu_yunhong@163.com.
Zeng HeDepartment of Biobank, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Ximianqiao Rd #20, Wuhou District, Chengdu, 610041, People's Republic of China. henkally@163.com.ORCID http://orcid.org/0000-0003-2649-5243
Tibet Autonomous Region People's Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNSichuan University · CNWuhou District People's Hospital, Chengdu · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Due to environmental hypoxia on the Tibetan Plateau, local residents often exhibit a compensative increase in hemoglobin concentration to maintain the body's oxygen supply. However, increases in hemoglobin and hematocrit (Hct) pose a serious challenge to the quality of stored suspended red blood cells (SRBCs) prepared from the blood of high-hemoglobin populations, especially populations at high altitude with polycythemia in Tibet. To explore the difference in storage quality of SRBCs prepared from plateau residents with a high hemoglobin concentration, blood donors were recruited from Tibet (> 3600 m) and Chengdu (≈ 500 m) and divided into a high-altitude control (HAC) group, high-altitude polycythemia (HAPC) group and lowland control (LLC) group according to their hemoglobin concentration and altitude of residence. The extracellular acidification rate (ECAR), pyruvate kinase (PK) activity and band 3 tyrosine phosphorylation were analyzed on the day of blood collection. Then, whole-blood samples were processed into SRBCs, and storage quality parameters were analyzed aseptically on days 1, 14, 21 and 35 of storage. Overall, we found that tyrosine 21 phosphorylation activated glycolysis by releasing glycolytic enzymes from the cytosolic domain of band 3, thus increasing glucose consumption and lactate accumulation during storage, in the HAPC group. In addition, band 3 tyrosine phosphorylation impaired erythrocyte deformability, accompanied by the highest hemolysis rate in the HAPC group, during storage. We believe that these results will stimulate new ideas to further optimize current additive solutions for the high-hemoglobin population in Tibet and reveal new therapeutic targets for the treatment of HAPC populations.

Indexed as

Altitude SicknessPolycythemiaAltitudeErythrocytesHemoglobinsHumansPhosphorylationTibetTyrosineHemoglobinsTyrosine

Identifiers

PMID37770909
PMCPMC10540337
OpenAlexW4387131768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.